CymaBay Therapeutics, Inc.·4

May 10, 5:55 PM ET

STUART LEWIS J 4

4 · CymaBay Therapeutics, Inc. · Filed May 10, 2021

Insider Transaction Report

Form 4
Period: 2021-05-10
STUART LEWIS J
Chief Commercial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-05-10+360,000360,000 total
    Exercise: $3.94Exp: 2031-05-09Common Stock (360,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/4 of the underlying shares on May 10, 2022 and vests as to 1/48 of the underlying shares monthly thereafter.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES